Your browser doesn't support javascript.
loading
Identification of potential novel drug resistance mechanisms by genomic and transcriptomic profiling of colon cancer cells with p53 deletion.
Kadioglu, Onat; Saeed, Mohamed; Mahmoud, Nuha; Azawi, Shaymaa; Mrasek, Kristin; Liehr, Thomas; Efferth, Thomas.
Afiliação
  • Kadioglu O; Department of Pharmaceutical Biology, Institute of Pharmaceutical and Biomedical Sciences, Johannes Gutenberg University, Mainz, Germany.
  • Saeed M; Department of Pharmaceutical Biology, Institute of Pharmaceutical and Biomedical Sciences, Johannes Gutenberg University, Mainz, Germany.
  • Mahmoud N; Department of Pharmaceutical Biology, Institute of Pharmaceutical and Biomedical Sciences, Johannes Gutenberg University, Mainz, Germany.
  • Azawi S; Institute of Human Genetics, Jena University Hospital, Friedrich Schiller University, Jena, Germany.
  • Mrasek K; Institute of Human Genetics, Jena University Hospital, Friedrich Schiller University, Jena, Germany.
  • Liehr T; Institute of Human Genetics, Jena University Hospital, Friedrich Schiller University, Jena, Germany.
  • Efferth T; Department of Pharmaceutical Biology, Institute of Pharmaceutical and Biomedical Sciences, Johannes Gutenberg University, Mainz, Germany. efferth@uni-mainz.de.
Arch Toxicol ; 95(3): 959-974, 2021 03.
Article em En | MEDLINE | ID: mdl-33515271

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Proteína Supressora de Tumor p53 / Aberrações Cromossômicas / Neoplasias do Colo / Resistencia a Medicamentos Antineoplásicos Tipo de estudo: Diagnostic_studies Limite: Humans Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Proteína Supressora de Tumor p53 / Aberrações Cromossômicas / Neoplasias do Colo / Resistencia a Medicamentos Antineoplásicos Tipo de estudo: Diagnostic_studies Limite: Humans Idioma: En Ano de publicação: 2021 Tipo de documento: Article